Characteristics of Tumor Cell Bioactivity in Oncogenic Osteomalacia
Overview
Endocrinology
Molecular Biology
Affiliations
Oncogenic osteomalacia is a condition where renal phosphate wasting occurs causing defective mineralisation, in the presence of a tumor. Cultures of cells were established from a hemangiopericytoma resected from a patient with oncogenic osteomalacia. Conditioned media from the cells inhibited phosphate uptake in opossum kidney cells and stimulated of cAMP in rat osteosarcoma cells, a standard parathyroid hormone (PTH)-like assay. This cAMP stimulation was suppressed by the PTH analogue, 3-34 bPTH and also by heat and trypsin treatment of the media. Tests of conditioned media for PTH and parathyroid hormone related protein (PTHrP) immunoreactivity were negative, however, and no hybridisation to probes for PTH, PTHrP or human stanniocalcin was detected in tumor cell RNA on Northern blot. These data support the hypothesis that tumors responsible for oncogenic osteomalacia produce a humoral substance that reduces renal phosphate reabsorption and provide evidence that the factor may act via PTH/PTHrP receptors.
Stanniocalcin 1 and ovarian tumorigenesis.
Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J J Natl Cancer Inst. 2010; 102(11):812-27.
PMID: 20484106 PMC: 2879417. DOI: 10.1093/jnci/djq127.
Oncogenic osteomalacia as a harbinger of recurrent osteosarcoma.
Lamont E, Cavaghan M, Brockstein B Sarcoma. 2008; 3(2):95-9.
PMID: 18521270 PMC: 2395412. DOI: 10.1080/13577149977712.
Rowe P, Garrett I, Schwarz P, Carnes D, Lafer E, Mundy G Bone. 2005; 36(1):33-46.
PMID: 15664000 PMC: 3361744. DOI: 10.1016/j.bone.2004.09.015.
Bresler D, Bruder J, Mohnike K, Fraser W, Rowe P J Endocrinol. 2004; 183(3):R1-9.
PMID: 15590969 PMC: 3357083. DOI: 10.1677/joe.1.05989.
The wrickkened pathways of FGF23, MEPE and PHEX.
Rowe P Crit Rev Oral Biol Med. 2004; 15(5):264-81.
PMID: 15470265 PMC: 3361894. DOI: 10.1177/154411130401500503.